Tiraje Çelkan

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders

Flora Peyvandi, Roberta Palla, Marzia Menegatti et al. · Journal of Thrombosis and Haemostasis · 2012 · 488 citations · Full text

Thrombosis, Coagulation Factor Activity, Medicine +11

Defective cytotoxic lymphocyte degranulation in syntaxin-11–deficient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients

Yenan T. Bryceson, Eva Rudd, Chengyun Zheng et al. · Blood · 2007 · 303 citations · Full text

Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial

Leonardo R. Brandão, Matteo Luciani, Lisa Bomgaars et al. · The Lancet Haematology · 2020 · 134 citations · Full text

Thrombosis, Venous Disease, Venous Thrombosis +8

Gain-of-function <i>IKZF1</i> variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation

Akihiro Hoshino, David Boutboul, Yuan Zhang et al. · Science Immunology · 2022 · 73 citations · Full text

DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia

Bahadır Batar, Mehmet Güven, Safa Barış et al. · Leukemia Research · 2008 · 72 citations

Hematological Malignancy, Xrcc1 Polymorphisms, Medicine +4